NOV 21, 2017 3:55 PM PST

Lab-Made Organoids for Drug Discovery

WRITTEN BY: Courtney Schaal

When you think of cellular model systems to study disease and potential therapeutics in a human context in the lab, you traditionally would think of animal models or 2-dimensional cell culture systems where primary or immortalized cells grow on plastic tissue culture plates in incubators kept at 37 degrees Celsius, 95% relative humidity, and 5% carbon-dioxide to simulate the human body.   More recently, researchers have shifted a strong focus toward the use of in vitro organoid systems which represents a major technological breakthrough for use in a wide variety of applications in basic, translational, and clinical research settings. 

So what is an “organoid”, exactly? They are 3-dimensional structures composed of human cells or tissue, which according to Aliyah Fatehullah et al, authors of a Nature Cell Biology review article on the subject matter, represents a “near physiological model facilitating a (more) accurate study of a range of in vivo biological processes including tissue renewal, stem cell/niche functions and tissue responses to drugs, mutation or damage”.  Essentially, these 3D systems are derived from self-organizing stem cells.  For example, embryonic stem cells are capable of differentiating into endoderm and ectoderm tissues when grown in 3D culture, which recapitulates their behavior in vivo.  Depending on the nutrients that are available to the stem cells from their environment, they can differentiate into multiple tissue types.  We have even been able to take samples from patients and create 3D organoids for laboratory study.  The ability to more accurately model the native state of cells in the body represents a new path forward in understanding basic biology of disease as well as pre-clinical testing of drugs to move them into clinical trials.

Scientists have successfully created organoids mimicking lung, liver, stomach, pancreas, kidneys, intestines, the brain, and even mammary glands that lactate (in addition to others).  While this is pretty remarkable to think about, the organoids are still not fully functional as you would find them in their systems-context in the body, but their ability to mimic the architecture and genetic make-up of their in vivo counterparts provides a valuable tool for study.

In 2014, scientists from the RIKEN Center for Developmental Biology in Kobe, Japan used mouse embryonic stem cells or induced pluripotent stem cells could be used to create a 3D retinal tissue which could develop the appropriate segments and nuclear layer found in vivo, and they could use this system to model advanced retinal degeneration.  Their study was a step forward toward being able to create retinal sheets for transplantation via 3D organoid cultures, to be used as a therapy for advanced retinal degenerative diseases.

Scientists such as Arnold Kriegstein at the Department of Neurology at the University of California in San Francisco and Jürgen Knoblich at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences have used stem cell technologies to generate brain organoids to study the pathogenesis of both acquired and inherited brain diseases such as Alzheimers and Parkinsons.  Brain organoids have also recently been used by other scientists to study the effect of the Zika virus, and to interrogate drugs which could potentially treat the virus.  A growing number of cancer researchers are also turning to 3D organoids to recapitulate their specific cancer types and to test potential novel therapeutics in these systems.

Organoids hold the potential to be a valuable tool for medical research that can aid in basic biological understanding, in testing drugs in a variety of disease states to move them into patients in the clinic, and organoids themselves may even have utility in acting as a therapeutic modality in the case of transplantation.

Sources: Stem Cell Reports, Nature Reviews NeuroScience, Nature Cell Biology, Forbes, The Sanger Institute, Pixabay

About the Author
You May Also Like
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
DEC 15, 2020
Clinical & Molecular DX
Who Should Get the COVID Vaccine First?
DEC 15, 2020
Who Should Get the COVID Vaccine First?
Drug developers’ frantic hunt for vaccines against SARS-CoV-2 has finally begun to bear fruit, with several vaccin ...
DEC 21, 2020
Cancer
Examining the Bioactive Components of an Alga Against Cancer
DEC 21, 2020
Examining the Bioactive Components of an Alga Against Cancer
Many of today’s drugs come from vast libraries of synthetic compounds built by chemists for big pharma. This drug ...
DEC 18, 2020
Drug Discovery & Development
Antibiotic Reduces Risk of Deafness
DEC 18, 2020
Antibiotic Reduces Risk of Deafness
Gentamicin is an antibiotic recently shown to reduce the risk of developing deafness according to a Stanford Medicine st ...
DEC 30, 2020
Drug Discovery & Development
Gene Therapy Cures Mice of Deafness
DEC 30, 2020
Gene Therapy Cures Mice of Deafness
Currently, around half a billion people suffer from hearing loss around the world. In about half of these cases, genetic ...
JAN 13, 2021
Immunology
Antibodies Gain the Upper Hand Against Sly Tumors
JAN 13, 2021
Antibodies Gain the Upper Hand Against Sly Tumors
Tumors use ingenious approaches to stay just out of reach of immune cells on patrol and avoid detection. Indeed, cancer ...
Loading Comments...